Market revenue in 2023 | USD 1,753.4 million |
Market revenue in 2030 | USD 2,189.1 million |
Growth rate | 3.2% (CAGR from 2023 to 2030) |
Largest segment | Hospital pharmacy |
Fastest growing segment | Hospital pharmacy |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospital pharmacy |
Key market players worldwide | GlaxoSmithKline, Bayer AG, Boehringer Ingelheim, Dr. Reddy’s Laboratories, Sanofi SA, Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries, Takeda Pharmaceutical Co Ltd, Pfizer Inc, Procter & Gamble Co |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antacids market will help companies and investors design strategic landscapes.
Hospital pharmacy was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe antacids market based on hospital pharmacy covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe antacids market , including forecasts for subscribers. This continent databook contains high-level insights into Europe antacids market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account